Publication:
A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia

2

Issued Date

2014-03-20

Resource Type

Letter

ISSN

15280020
00064971

DOI

10.1182/blood-2013-11-538470

Other identifier(s)

2-s2.0-84897487469

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Blood. Vol.123, No.12 (2014), 1956-1957

Suggested Citation

Poramin Patthamalai, Suthat Fuchareon, Nattawara Chaneiam, Richard G. Ghalie, David H.K. Chui, Michael S. Boosalis, Susan P. Perrine A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia. Blood. Vol.123, No.12 (2014), 1956-1957. doi:10.1182/blood-2013-11-538470 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/33285

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia

Author(s)

Poramin Patthamalai
 Suthat Fuchareon
 Nattawara Chaneiam
 Richard G. Ghalie
 David H.K. Chui
 Michael S. Boosalis
 Susan P. Perrine

Other Contributor(s)

Mahidol University
 HemaQuest Pharmaceuticals
 Boston University School of Medicine

Keyword(s)

Biochemistry, Genetics and Molecular Biology
 Immunology and Microbiology
 Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/123456789/33285

Collections

Scopus 2011-2015